HIGHLIGHTS
- who: Escherichia coli and collaborators from the University of Florence, Italy have published the article: Emergence of a novel hybrid mcr-1 -bearing plasmid in an NDM-7-producing ST167 Escherichia coli strain of clinical origin, in the Journal: (JOURNAL)
- what: Polymyxin is regarded as the last line of defense in the clinical treatment of CRE infections.
- how: Based on its structural features the authors proposed a putative IS26-mediated formation model of this novel IncHI2/ HI2A/N/FII/FIA hybrid plasmid. Close inspection of the overall structure of pEC15-MCR-50 the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.